Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1
OBR Daily - Our Oncology Focused E-News Service

Register for OBR daily

Warning: Missing argument 1 for showSidebarBanner(), called in /home2/don/public_html/sidebar_obrgreen.php on line 38 and defined in /home2/don/public_html/include/banners.php on line 243

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

FPRX $20.50 4.7500 +30.16%
ARIA $7.17 0.6500 +9.97%
CRIS $1.44 0.1250 +9.54%
CNDO $2.05 0.1700 +9.04%
TSRO $33.21 2.4750 +8.05%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

GALE $1.88 -0.1901 -9.18%
CERU $4.84 -0.3700 -7.10%
FATE $3.98 -0.2500 -5.91%
MRTX $15.09 -0.9200 -5.75%
BIND $7.13 -0.4200 -5.56%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Pfizer Says Arthritis Drug Candidate Cut Symptoms in Study

(Bloomberg) Apr 15, 2011 - Pfizer Inc., the world's biggest drugmaker, said its experimental rheumatoid arthritis pill reduced symptoms of the disease in a study that may help it wrest part of a $12 billion market from rivals.
read article 

Lilly, Amylin Diabetes Drug Wins EU Recommendation

(Reuters) Apr 15, 2011 - An experimental diabetes medicine from Eli Lilly and Amylin Pharmaceuticals, that patients need to inject only once a week, has been recommended for approval by European regulators.
read article 

Molecular Templates Announces Research Collaboration with Memorial Sloan-Kettering Cancer Center

(Morningstar) Apr 15, 2011 - Molecular Templates announced today that they have entered into a research collaboration with Memorial Sloan-Kettering Cancer Center (MSKCC) to develop Engineered Toxin Bodies (ETB) for lymphomas.
read article 

Mother and Son Approach Second Cancer Run with New Hope

(Kansas City Star) Apr 14, 2011 - One year ago Olathe mother Deliece Hofen and her son Braden, then just 5, were both in the midst of intense cancer treatments.
read article 

Florida Comprehensive Care Network (FCCN) and ITA Partners Enter into a Long-Term Strategic Relationship -- FCCN Network Physicians toAdopt eviti®

(CNBC) Apr 13, 2011 - The Florida Comprehensive Care Network (FCCN) and ITA Partners, Inc. (ITA) have signed a long-term strategic agreement under which FCCN will use eviti®, ITA's oncology decision-support platform, across its network of oncologists. ITA is an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care.
read article 

Promoting Quality Oncology Care for Members, DAKOTACARE Turns to ITA Partners' eviti® Platform for Evidence-Based Treatment Intelligence

(CNBC) Apr 14, 2011 - DAKOTACARE, a South Dakota managed care organization, owned by the South Dakota State Medical Association and focused on keeping patient care decisions in the hands of physicians, has contracted to implement ITA Partners' proprietary web-based oncology decision-support platform -- eviti® -- across its comprehensive local network of physicians.
read article 

Pancreatic Cancer Vaccine Could Prolong Patients' Lives

(Fox News) Apr 14, 2011 - A pancreatic cancer vaccine is being studied, and more than 1,000 patients with an advanced stage of the cancer have joined a trial at 53 hospitals in the U.K., BBC News reported.
read article 

Education on Newly Approved Melanoma Therapy (Ipilimumab)

(ASCO in Action) Apr 15, 2011 - Ipilimumab, a recently approved therapy for unresectable or metastatic melanoma, has a complex safety profile that may not normally be seen in practice.
read article 

FDA Finds More Blood Cancer with TNF Blocker Drugs

(Reuters) Apr 14, 2011 - U.S. health regulators have received more reports of rare blood cancer in young patients taking a class of anti-inflammatory drugs used to treat digestive disorders.
read article 

Breast Device Recall Made Most Severe

(New York Times) Apr 14, 2011 - The recall of a medical device that left particles of tungsten in women's breasts has been classified as the most serious type of recall, one involving "situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death" the Food and Drug Administration said on Wednesday.
read article (free registration required) 

Susan G. Komen for the Cure® Commits Nearly $58 Million in 2011 to Tackle Toughest Issues with New, Innovative Approaches to Breast Cancer Research

(Susan G. Komen) Apr 14, 2011 - Developing genetic interventions that target the immune system and creating personalized cancer vaccines are just two of more than 80 innovative research grants being funded this year by Susan G. Komen for the Cure®.
read press release 

Duke Leads the Way for New Melanoma Therapy

(Duke Cancer Institute) April 14, 2011 - About half of the 60,000 annual cases of melanoma—the most serious type of skin cancer—occur in the arms or legs. While most patients can be cured with surgical excision of their tumor, up to 10 percent of patients have a recurrence that metastasizes (or spreads) to other locations in the same extremity in which the tumor first developed but has not spread to the rest of the body.
read press release 

A Good Diet Includes Many Cancer-Fighting Foods: Expert

(U.S. News & World Report) Apr 15, 2011 - Losing weight can help reduce your risk of cancer if you're overweight or obese, but not all diet plans are effective in lowering that risk, an expert says.
read article 

ImmunoCellular Therapeutics' Cancer Vaccine: Safety and Preliminary Efficacy Results for Glioblastoma Trial Presented at American Academy of Neurology Annual Meeting

(StreetInsider) Apr 15, 2011 - ImmunoCellular Therapeutics, Ltd., announced that Surasak Phuphanich, MD, Principal Investigator of the Phase I clinical trial of ImmunoCellular's lead dendritic cell cancer vaccine candidate for glioblastoma multiforme (GBM) presented safety and preliminary efficacy data yesterday at the American Academy of Neurology (AAN) 63rd Annual Meeting.
read article 

Enzyme Crucial to DNA Replication May Provide Potent Anti-Cancer Drug Target

(ScienceDaily) Apr 14, 2011 - An enzyme essential for DNA replication and repair in humans works in a way that might be exploited as anti-cancer therapy, say researchers at The Scripps Research Institute and Lawrence Berkeley National Laboratory.
read article 

Does Prostate Cancer Screening Reduce Mortality Rates?

(Yahoo! Finance) Apr 14, 2011 - Dr. David Samadi, Vice Chairman, Department Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, expressed concern today regarding the conclusions of a study published this month in the British Medical Journal (BMJ).
read article 

NIH Researchers Complete Whole-exome Sequencing of Skin Cancer

(NCI) Apr 15, 2011 - A team led by researchers at the National Institutes of Health is the first to systematically survey the landscape of the melanoma genome, the DNA code of the deadliest form of skin cancer.
read press release 

EU Body Relaxes Curb on Avastin Breast Cancer Use

(Reuters) Apr 15, 2011 - European regulators said on Friday they were relaxing curbs on the use of Roche's top-selling cancer drug Avastin to allow its use with Xeloda, another type of chemotherapy that is also made by Roche.
read article 

Estrogen's Role in Breast Cancer Can Fluctuate

(U.S. News & World Report) Apr 15, 2011 - Is estrogen breast cancer's friend or foe? A recent study in the Journal of the American Medical Association, which analyzed data from the massive Women's Health Initiative, suggested the latter when it found a reduced risk of breast cancer in women who had been on short-term estrogen therapy.
read article 

Blood Test Could Predict Metastasis Risk in Melanoma

(AACR) Apr 15, 2011 - Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
read press release 

Clinical Trial at The Cancer Institute of New Jersey Studies Combination of Steroid and Experimental Drug to Treat Prostate Cancer

(UMDNJ-Robert Wood Johnson) Apr 8, 2011 - Investigators at The Cancer Institute of New Jersey have just launched a new clinical trial that explores the effects of a new type of hormone therapy in the treatment of certain prostate cancers that have spread beyond the prostate.
read press release 

What ‘Big Medicine’ Means for Doctors and Patients

(NYT/Well Blog) Apr 14, 2011 - A colleague described a recent meeting at his hospital by saying that five years ago, most of the physicians in the room had been like him, independent owners of small group practices. Now a majority were employees of the hospital
read article (paid subscription required) 

As Generics Near, Makers Tweak Erectile Drugs

(New York Times) Apr 13, 2011 - The multibillion-dollar market is being driven by novel applications to compete with coming generics.
read article (paid subscription required) 

Eisai’s Perampanel Didn’t Significantly Reduce Epileptic Seizures in Study

(Bloomberg) Apr 14, 2011 - Eisai Co.’s experimental epilepsy drug didn’t cut seizure rates significantly more than a placebo in patients who didn’t improve on previous treatments, a researcher said at the American Academy of Neurology meeting.
read article 

Doctor-Turned-Trader Paid Cash for Stock Tips

(Reuters) Apr 13, 2011 - An Ivy League-trained doctor-turned-stock-picker has been charged with insider trading, accused of showering a French physician with cash and a luxury trip to New York in exchange for secret details on a biotechnology company.
read article